Burden of illness in painful diabetic peripheral neuropathy: The patients' perspectives

被引:180
作者
Gore, Mugdha
Brandenburg, Nancy A.
Hoffman, Deborah L.
Tai, Kei-Sing
Stacey, Brett
机构
[1] Avalon Hlth Solut Inc, Philadelphia, PA 19102 USA
[2] Pfizer Inc, New York, NY USA
[3] Oregon Hlth & Sci Univ, Pain Management Ctr, Portland, OR 97201 USA
关键词
painful diabetic peripheral neuropathy; burden of illness; human burden; economic burden; pain experience; health surveys;
D O I
10.1016/j.jpain.2006.04.013
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Our goal was to assess the patient-level burden among subjects with painful diabetic peripheral neuropathy (DPN). Community-based physicians recruited patients with painful DPN (N = 255) between April and October 2003. Patients completed a survey on pain experience (Brief Pain Inventory-DPN [BPI-DPN]), health status (EuroQoL [EQ-5D]), healthcare utilization (consults, prescription [Rx], and over-the-counter [OTC] medications), and work productivity/functioning. Patients were 61 +/- 12.8 years old and had diabetes for 12 +/- 10.3 years and painful DPN for 6.4 +/- 6.4 years; 25.5 and 62.7% had other neuropathic and musculoskeletal pain conditions. Average and worst pain scores (BPI-DPN, 0-10 scales) were 5.0 +/- 2.5 and 5.6 +/- 2.8. The mean EQ-5D utility was .5 +/- .3 (range = -.594-1). A majority (87.4%) took pain medications (Rx/OTC) in the preceding week: an average of 3.8 +/- 3.9 Rx and 2.1 +/- 1.3 OTC medications. Nearly half (46.7%) received NSAIDs. Other frequently reported medications were short/long-acting opioids (43.1%), anticonvulsants (27.1%), selective serotonin reuptake inhibitors/selective norepinephrine reuptake inhibitors (18%), and tricyclic antidepressants (11.4%). During the preceding 3 months, 59.6% had >= 2 health professional consults; 59% reported decreased home productivity; 85.5% reported activity limitations; and 64.4% of patients who worked (N = 73) reported missing work/decreased work productivity due to painful DPN. Our results underscore a substantial patient-level burden among subjects with painful DPN. Perspective: Information on the patient-level burden among painful DPN sufferers in the U.S. was previously lacking. Our results suggest that this burden is significant, evidenced by moderate-to-high pain levels, polypharmacy, health resource use, and work/activity limitations. Results also suggest suboptimal pain management and low levels of satisfaction with treatments. (c) 2006 by the American Pain Society.
引用
收藏
页码:892 / 900
页数:9
相关论文
共 41 条
  • [1] BACKONJA MM, 1998, JAMA-J AM MED ASSOC, V281, P1831
  • [2] Pain epidemiology and health related quality of life in chronic non-malignant pain patients referred to a Danish multidisciplinary pain center
    Becker, N
    Thomsen, AB
    Olsen, AK
    Sjogren, P
    Bech, P
    Eriksen, J
    [J]. PAIN, 1997, 73 (03) : 393 - 400
  • [3] Diabetic peripheral neuropathy and quality of life
    Benbow, SJ
    Wallymahmed, ME
    MacFarlane, IA
    [J]. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 1998, 91 (11) : 733 - 737
  • [4] Painful diabetic neuropathy
    Benbow, SJ
    MacFarlane, IA
    [J]. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 13 (02) : 295 - 308
  • [5] EuroQol: The current state of play
    Brooks, R
    [J]. HEALTH POLICY, 1996, 37 (01) : 53 - 72
  • [6] Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62)
    Clarke, P
    Gray, A
    Holman, R
    [J]. MEDICAL DECISION MAKING, 2002, 22 (04) : 340 - 349
  • [7] Cleeland CS, 1991, EFFECT CANC QUALITY, P293
  • [8] Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes
    Daousi, C
    MacFarlane, IA
    Woodward, A
    Nurmikko, TJ
    Bundred, PE
    Benbow, SJ
    [J]. DIABETIC MEDICINE, 2004, 21 (09) : 976 - 982
  • [9] Advances in neuropathic pain - Diagnosis, mechanisms, and treatment recommendations
    Dworkin, RH
    Backonja, M
    Rowbotham, MC
    Allen, RR
    Argoff, CR
    Bennett, GJ
    Bushnell, MC
    Farrar, JT
    Galer, BS
    Haythornthwaite, JA
    Hewitt, DJ
    Loeser, JD
    Max, MB
    Saltarelli, M
    Schmader, KE
    Stein, C
    Thompson, D
    Turk, DC
    Wallace, MS
    Watkins, LR
    Weinstein, SM
    [J]. ARCHIVES OF NEUROLOGY, 2003, 60 (11) : 1524 - 1534
  • [10] Pregabalin for the treatment of postherpetic neuralgia - A randomized, placebo-controlled trial
    Dworkin, RH
    Corbin, AE
    Young, JP
    Sharma, U
    LaMoreaux, L
    Bockbrader, H
    Garofalo, EA
    Poole, RM
    [J]. NEUROLOGY, 2003, 60 (08) : 1274 - 1283